Control of Visceral Leishmaniasis by Immunotherapeutic and Prophylactic Strategies
Visceral leishmaniasis (VL) or kala-azar is the most dreadful of all forms of leishmaniasis caused by Leishmania donovani in Old World and Leishmania chagasi and/or Leishmania infantum in New World affecting millions of people worldwide. In active VL, macrophages host the replicating amastigotes in...
Format: | eBook |
---|---|
Language: | English |
Published: |
Frontiers Media SA
2015
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | Open Access: DOAB, download the publication Open Access: DOAB: description of the publication |
Similar Items
-
Targeted immunology for prevention and cure of VL
by: NAHID eALI, et al.
Published: (2014-12-01) -
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis
by: Mariana Costa Duarte, et al. -
Role of Cytokines in Experimental and Human Visceral Leishmaniasis
by: Mukesh Samant, et al.
Published: (2021-02-01) -
An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy
by: Ana Alice Maia Gonçalves, et al.
Published: (2019-12-01) -
Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
by: Abdus Sabur, et al.
Published: (2018-01-01)